Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.79% is 47% below its 5-year average of 1.49%, around the middle of its 5-year range (0.00%–2.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.57% below its 12-month average of 0.91%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.79%.
DEBT TO ASSETS RATIO
0.79%
DEBT TO ASSETS RATIO AVG TTM
0.91%
DEBT TO ASSETS RATIO AVG 3Y
1.25%
DEBT TO ASSETS RATIO AVG 5Y
1.49%
DEBT TO ASSETS RATIO AVG 10Y
1.21%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.57%
CURRENT VS 3Y AVG
-37.06%
CURRENT VS 5Y AVG
-47.22%
CURRENT VS 10Y AVG
-34.96%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+614.81%
vs the sector median at left
Crescent Biopharma, Inc.
Market Cap
$517.79M
Debt to Assets Ratio
0.79%
TTM Avg
0.91%
3Y Avg
1.25%
5Y Avg
1.49%
Market Cap
$517.73M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$547.86M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$487.30M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$551.09M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Crescent Biopharma, Inc. (CBIO) | $517.79M | 0.79% | 0.91% | 1.25% | 1.49% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | 0.13% | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $519.25M | 0.07% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $491.93M | 0.66% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 0.33% | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 0.02% | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | 0.00% | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | 0.00% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 0.01% | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.03% | N/A | N/A | N/A |
Debt/Assets
0.8%
Debt/Equity
0.01
Current Ratio
9.66
Interest Coverage
-69.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.79% |
| 2026-03-31 | 0.77% |
| 2025-12-31 | 0.68% |
| 2025-09-30 | 1.26% |
| 2025-06-30 | 1.04% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.60% |
| 2024-09-30 | 1.67% |
| 2024-06-30 | 1.84% |
| 2024-03-31 | 1.84% |
| 2023-12-31 | 1.78% |
| 2023-09-30 | 1.90% |
| 2023-06-30 | 2.05% |
| 2023-03-31 | 0.95% |
| 2022-12-31 | 1.77% |
| 2022-09-30 | 2.11% |
| 2022-06-30 | 2.21% |
| 2022-03-31 | 2.06% |
| 2021-12-31 | 2.04% |
| 2021-09-30 | 2.00% |
| 2021-06-30 | 1.92% |
| 2021-03-31 | 1.89% |
| 2020-12-31 | 1.97% |
| 2020-09-30 | 2.01% |
| 2020-06-30 | 2.04% |
| 2020-03-31 | 2.12% |
| 2019-12-31 | 2.16% |
| 2019-09-30 | 2.06% |
| 2019-06-30 | 2.03% |
| 2019-03-31 | 2.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
